AVCT Tag

Avacta Group plc Interim Results

Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and research reagents, announces its unaudited interim results for the period ended 31 January 2018. The Group has delivered strongly...

Read More

Avacta Group plc Interim Results

Avacta Group plc, a leading healthcare technology, reagents and consumables company providing proprietary analytical and diagnostics solutions to the life sciences/healthcare sector, is pleased...

Read More

Avacta Group plc Trading Update

Avacta Group plc, a leading provider of analytical and diagnostic technologies and services to the pharmaceutical and animal healthcare sectors, today announces the following trading update for the...

Read More